We are proud to share newly published clinical data confirming that Essilor Stellest 2.0 spectacle lenses with H.A.L.T.* (Highly Aspherical Lenslet Target) MAX technology are significantly more efficacious in slowing axial elongation compared to first-generation Essilor Stellest lenses with H.A.L.T.* technology†1. Published in the medical journal Translational Vision Science & Technology (TVST), the findings are based on a one-year contralateral crossover clinical trial involving children aged 6–10 in Singapore. This next-generation innovation represents another key milestone in our mission to tackle childhood myopia. With over four decades of research and experience in myopia management, we remain committed to advancing science-led solutions that deliver better outcomes for children worldwide. Read more: https://lnkd.in/derQAJze * H.A.L.T., Highly Aspherical Lenslet Target. † Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children. 1. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. doi:10.1167/tvst.14.11.9. #WeAreEssilorLuxottica
À propos
We are EssilorLuxottica, a global leader in the design, manufacture and distribution of advanced vision care products, eyewear and med-tech solutions. Our Mission is to help people around the world to see more and be more by addressing their evolving vision needs, personal style aspirations and desire to feel more connected to the world around them. We are home to the most innovative lens technologies, including Varilux, Stellest and Transitions, iconic brands such as Ray-Ban, Oakley and Supreme, the most desired luxury licensed brands and world-class retailers including Sunglass Hut, LensCrafters, Vision Express and Apollo. Backed by robust R&D investments, distinctive capabilities and a top-quality asset portfolio, we drive innovation across categories, from cutting edge medical instruments and solutions for eye health to category-defining smart glasses, all of which push the boundaries of the industry and reimagine the eyes as a gateway to new possibilities. With over 200,000 employees across 150 countries, 600 operations facilities, serving 300,000 eye care professionals and operating 18,000 stores, the Group generated consolidated revenue of Euro 26.5 billion in 2024. Our OneSight EssilorLuxottica Foundation has given access to sustainable vision care to nearly 1 billion people in underserved communities. Our ambition is clear. We are building a platform where the eyes are the gateway to new possibilities – bridging the gap between the digital world and human experience. At EssilorLuxottica, we are Empowering Humans.
- Site web
-
https://www.essilorluxottica.com
Lien externe pour EssilorLuxottica
- Secteur
- Industrie manufacturière
- Taille de l’entreprise
- + de 10 000 employés
- Siège social
- Paris
- Type
- Société cotée en bourse
Lieux
-
Principal
Obtenir l’itinéraire
1-6, Rue Paul Cézanne
Paris, FR
-
Obtenir l’itinéraire
Piazzale Luigi Cadorna, 3
Milan, IT
Employés chez EssilorLuxottica
-
Thomas Chun
Executive Leader in Digital Transformation | Turning Data and Analytics into Market-Leading Product and GTM Solutions
-
Gohar Butt
Technology Leader | Digital Transformation | Cloud & Cybersecurity | M&A Integration
-
Clement Viard
Sr Directeur Stratégie Produit, Product management - Executive MBA ESCP Europe, Ingénieur Centrale Marseille
-
Eric Carpentier
Global HRIS
Nouvelles
-
We are pleased to announce our membership in the Collaborative Community of Ophthalmic Innovation (CCOI), a global catalyst uniting patients, clinicians, researchers, regulators, and industry to accelerate breakthrough science into real-world solutions. Joining the Community at the highest level of industry participation reflects our dedication to advancing ophthalmic science through industry collaboration. Read more: https://lnkd.in/d5nDVb62 #WeAreEssilorLuxottica
-
-
One of the key pillars of our #FinHance program is the strong network our participants build across the organization and the mentorship they receive along the way. From day one, they are guided by experienced leaders who help them navigate complex challenges, build confidence, and unlock their potential. This continuous exchange of ideas and feedback fosters a culture of trust and accelerated learning. The FinHance journey is not a solo one - it’s powered by collaboration, connection, and the shared commitment of our global community in shaping the leaders of the future. Discover how the program supported Czarilyn Capuso and George Gunning’s professional growth and their unique journeys. #WeAreEssilorLuxottica
-
We are proud to announce the evolution of our Essilor Stellest platform, strengthening our commitment to tackling the global rise of myopia – a condition expected to affect 740 million children by 2050*. Our purpose is clear: turning evidence into action and technology into empowerment. By combining advanced lens technology with smart features, we are shaping the future of eye health for the next generation. Read more: https://lnkd.in/dMF7_Kd9 #WeAreEssilorLuxottica *Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006
-
-
Persol has taken a meaningful step forward in helping strengthen its commitment to circularity. From Nov. 3-9, a Care Week event is being held for the first time at Persol’s Brera boutique in Milan, inviting consumers to meet an artisan in-store and restore their beloved Persol eyewear. Dedicated services, such as frame polishing, fit & adjustments, and screw and nose pad replacement, offered a tangible way to give new life to iconic pieces — reflecting Persol’s commitment to impeccable quality and enduring appeal. Read more: https://lnkd.in/dWANQzN8 #WeAreEssilorLuxottica
-
-
#FinHance, our international rotational program, continues shaping the careers of internal young talents and future leaders in the Finance, Investor Relations, Compliance and Real Estate community. As testified by our alumni and current participants, the program made them gain invaluable experience, deepening their expertise across diverse financial functions and enhancing leadership skills through hands-on challenges. New participants can expect to follow in their footsteps, embracing the opportunity to learn, grow, and navigate complex business landscapes, all while benefiting from the rich network and mentorship cultivated during the experience. Check out what Daniel Bacon and Ilaria Peruzzo said about their experiences so far! #WeAreEssilorLuxottica
-
At the 28th European Vision and Eye Research (EVER) Congress in Florence (Italy), we showcased the future of myopia management with a spotlight on our latest innovation, Essilor Stellest 2.0 spectacle lenses. Our global medical advisor for myopia, Saoirse McCrann led an insightful session presenting data from a clinical trial on Essilor Stellest 2.0 lenses, featuring Highly Aspherical Lenslet Target (H.A.L.T.) MAX technology designed to slow myopia progression in children. The study demonstrated significantly greater efficacy in slowing axial elongation in children compared to spectacle lenses with H.A.L.T. technology*1. Moderated by Giorgio Parisotto, the session sparked rich dialogue among researchers and eye care professionals dedicated to advancing evidence-based approaches to myopia management. Our booth saw strong engagement, offering attendees the opportunity to explore how Essilor Stellest lenses combine science and technology to deliver improved clinical outcomes. #WeAreEssilorLuxottica * Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children. EssilorLuxottica data on file (2025). 1 Raveendran RN, et al. Effect of increased power and asphericity of lenslets on myopia control efficacy: 6-month interim results of a contralateral crossover clinical trial. Invest Ophthalmol Vis Sci. 2025;66:5192.
-
-
In a groundbreaking collaboration timed with World Sight Day, our OneSight EssilorLuxottica Foundation has joined forces with the Roger Federer Foundation to deliver essential vision care to thousands of schoolchildren across Zambia. This partnership marks a significant stride in making good vision accessible to all, aligning with global commitments to health and education. The pilot project, launched on October 9, successfully screened over 2,700 learners across community schools in the Mazabuka, Mbala, and Nyimba districts. More than 200 individuals received prescription eyewear or sunglasses free of charge through this initiative directly on-site. Read more: https://lnkd.in/dgubTC5z #WeAreEssilorLuxottica
-
-
For the first time, we proudly participated as a Platinum Sponsor at the 19th World Association of Eye Hospitals (WAEH) Annual Meeting in Lausanne and Paris. Dr. Norbert Gorny shared our forward-looking scientific vision, reaffirming our commitment to advancing eye health worldwide through innovation, med-tech and strategic collaborations. Our booth, powered by Heidelberg Engineering, served as a platform to deepen partnerships with leading eye hospitals and institutions. It was inspiring to connect, exchange ideas and explore new pathways to elevate ophthalmic care on a global scale. A heartfelt thank you to the WAEH | World Association of Eye Hospitals organizers and all participants for creating a forum of shared purpose and lasting impact – together, we are accelerating progress for a more promising future in vision care. #WeAreEssilorLuxottica
-
-
Watch the highlights from our Visionary Horizons symposium, a moment dedicated to advancing eye health through science, innovation, and technology. Organized in collaboration with Heidelberg Engineering, world-leading experts took the stage to share their perspectives on the latest advancements in ophthalmology, from retinal and anterior segment diseases to myopia and optic neuropathies. #WeAreEssilorLuxottica
Pages affiliées
Pages similaires
Parcourir les offres d’emploi
Financement
Dernier round
Capital après introduction en Bourse3 526 893 148,00 $US
Investisseurs